Prognostic impact of TID in regadenoson MPI: Some patients and certain events.
Prognostic impact of TID in regadenoson MPI: Some patients and certain events.
复制标题
TID 对 regadenoson MPI 的预后影响:一些患者和某些事件。
DOI:
10.1007/s12350-015-0299-9
复制
发表时间:
2016
期刊:
影响因子:
--
通讯作者:
Bourque,JamiesonM
中科院分区:
文献类型:
--
作者:
Löffler,AdriánI;Bourque,JamiesonM
Single-photon emission-computed tomographic (SPECT) myocardial perfusion imaging (MPI) has incremental diagnostic and prognostic value over exercise stress electrocardiography, and the assessment of transient ischemic dilation (TID) is a key contributor to its ability to detect higher risk patients. The diagnostic and prognostic role of TID has been evaluated extensively in those undergoing exercise MPI. 1, 2 However, approximately 50% of the* 10 million MPI studies performed annually in the US undergo pharmacologic MPI, 3 the majority receiving regadenoson for vasodilator stress due to its improved tolerability by patients, safety profile, and ease of administration. 4 Given the high prevalence of this testing, the significance of TID in this population is of high importance. The diagnostic role of TID in regadenoson MPI has been assessed previously, but the prognostic impact has not determined.In this issue of the Journal, Lester et al provide the first analysis of the prognostic utility of TID with regadenoson MPI. In this well-performed study, Lester et al assessed the prognostic impact of an abnormal TID ratio of 1.33 on a composite of cardiac death, myocardial infarction (MI), or late coronary revascularization (CR) in 887 patients over a mean of 29 months; 75% of the cohort had an abnormal perfusion pattern. TID was